Largest biotechnology: pharmaceutical preparations companies
Every US-listed biotechnology: pharmaceutical preparations company we cover, 500 of them, ranked by market capitalisation, with revenue and earnings taken from their SEC filings.
Combined market cap
$5.036 T
5.1% of all US-listed value
Companies
500
Ranked #5 of 152 industries
Average
$10.073 B
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 1 | Eli Lilly & CoLLY | $1.08T | $1,150.99 | -1.64% | United States |
| 2 | Johnson & JohnsonJNJ | $648.7B | $269.17 | -0.01% | United States |
| 3 | AbbVieABBV | $468.4B | $265.08 | -0.05% | United States |
| 4 | Merck & Co.MRK | $365.3B | $148.08 | -1.88% | United States |
| 5 | NovartisNVS | $272.3B | $142.71 | +1.01% | Switzerland |
| 6 | AstrazenecaAZN | $253.3B | $163.33 | -2.99% | United Kingdom |
| 7 | Abbott LaboratoriesABT | $179.1B | $103.49 | -0.19% | United States |
| 8 | Novo Nordisk A SNVO | $169.0B | $38.17 | -3.12% | Denmark |
| 9 | PfizerPFE | $160.6B | $28.18 | +0.90% | United States |
| 10 | Vertex PharmaceuticalsVRTX | $130.9B | $516.34 | +0.26% | United States |
| 11 | Bristol Myers SquibbBMY | $124.9B | $61.15 | -1.77% | United States |
| 12 | SanofiSNY | $101.6B | $41.66 | -2.00% | France |
| 13 | GSKGSK | $100.5B | $49.71 | -1.99% | United Kingdom |
| 14 | Regeneron PharmaceuticalsREGN | $82.6B | $801.82 | -0.26% | United States |
| 15 | Takeda PharmaceuticalTAK | $59.4B | $18.81 | -0.74% | Japan |
| 16 | Teva Pharmaceutical IndustriesTEVA | $45.5B | $39.01 | -1.29% | Israel |
| 17 | BeOne MedicinesONC | $41.5B | $365.00 | -0.84% | Cayman Islands |
| 18 | Royalty PharmaRPRX | $33.1B | $57.65 | -1.49% | United States |
| 19 | Alnylam PharmaceuticalsALNY | $33.0B | $246.51 | -2.04% | United States |
| 20 | ZoetisZTS | $29.6B | $71.61 | -1.72% | United States |
| 21 | Roivant SciencesROIV | $26.6B | $36.82 | -3.66% | United Kingdom |
| 22 | InsmedINSM | $25.8B | $118.34 | -2.05% | United States |
| 23 | United TherapeuticsUTHR | $21.0B | $489.42 | -1.64% | United States |
| 24 | ViatrisVTRS | $19.7B | $17.12 | -0.35% | United States |
| 25 | Jazz PharmaceuticalsJAZZ | $15.2B | $234.88 | -2.37% | Ireland |
| 26 | Ascendis Pharma A/SASND | $14.7B | $223.13 | -6.08% | Denmark |
| 27 | Summit TherapeuticsSMMT | $13.1B | $16.45 | -3.91% | United States |
| 28 | BridgeBio PharmaBBIO | $12.8B | $65.71 | -5.08% | United States |
| 29 | Corcept TherapeuticsCORT | $12.2B | $112.94 | -3.88% | United States |
| 30 | Biomarin PharmaceuticalBMRN | $12.0B | $62.21 | -1.83% | United States |
| 31 | Madrigal PharmaceuticalsMDGL | $11.9B | $513.02 | -1.12% | United States |
| 32 | Elanco Animal HealthELAN | $11.3B | $22.57 | -1.57% | United States |
| 33 | Dr Reddys LaboratoriesRDY | $10.3B | $12.39 | -1.43% | India |
| 34 | Axsome TherapeuticsAXSM | $10.1B | $193.45 | -4.75% | United States |
| 35 | Arrowhead PharmaceuticalsARWR | $9.46B | $66.96 | -6.82% | United States |
| 36 | CytokineticsCYTK | $9.15B | $65.81 | -2.63% | United States |
| 37 | Protagonist TherapeuticsPTGX | $8.98B | $138.70 | -4.39% | United States |
| 38 | Tg TherapeuticsTGTX | $8.57B | $56.00 | -3.63% | United States |
| 39 | AbivaxABVX | $8.10B | $94.13 | -4.23% | France |
| 40 | Praxis Precision MedicinesPRAX | $7.88B | $282.12 | -6.16% | United States |
| 41 | Spyre TherapeuticsSYRE | $7.77B | $88.17 | -4.13% | United States |
| 42 | Ionis PharmaceuticalsIONS | $7.30B | $43.93 | -3.98% | United States |
| 43 | AlkermesALKS | $7.07B | $42.13 | -2.68% | Ireland |
| 44 | Belite BioBLTE | $6.79B | $168.67 | -3.81% | United States |
| 45 | Rhythm PharmaceuticalsRYTM | $6.76B | $98.24 | -1.04% | United States |
| 46 | Amneal PharmaceuticalsAMRX | $6.73B | $19.33 | -0.87% | United States |
| 47 | LiquidiaLQDA | $6.04B | $67.49 | -1.68% | United States |
| 48 | Ligand PharmaceuticalsLGND | $5.95B | $298.41 | -0.03% | United States |
| 49 | Kiniksa Pharmaceuticals InternationalKNSA | $5.94B | $76.08 | -2.46% | United States |
| 50 | Mirum PharmaceuticalsMIRM | $5.80B | $89.32 | -2.27% | United States |
| 51 | Travere TherapeuticsTVTX | $5.64B | $59.83 | -0.75% | United States |
| 52 | Cogent BiosciencesCOGT | $5.45B | $31.41 | -3.74% | United States |
| 53 | Dianthus TherapeuticsDNTH | $5.23B | $93.44 | -4.99% | United States |
| 54 | Ptc TherapeuticsPTCT | $5.20B | $62.34 | -5.49% | United States |
| 55 | GrifolsGRFS | $4.95B | $7.20 | -3.29% | Spain |
| 56 | ErascaERAS | $4.88B | $13.95 | -10.32% | United States |
| 57 | Viking TherapeuticsVKTX | $4.86B | $41.65 | +1.96% | United States |
| 58 | VeradermicsMANE | $4.84B | $115.78 | -2.00% | United States |
| 59 | Genmab A/SGMAB | $4.46B | $34.75 | -1.33% | Denmark |
| 60 | Edgewise TherapeuticsEWTX | $4.46B | $41.05 | -7.77% | United States |
| 61 | Acadia PharmaceuticalsACAD | $4.38B | $25.43 | -3.71% | United States |
| 62 | Indivior PharmaceuticalsINDV | $4.24B | $35.91 | -0.77% | United Kingdom |
| 63 | Tango TherapeuticsTNGX | $4.12B | $24.45 | -4.23% | United States |
| 64 | Parabilis MedicinesPBLS | $4.06B | $33.31 | -12.73% | United States |
| 65 | AbCellera BiologicsABCL | $3.99B | $12.31 | -2.69% | Canada |
| 66 | Amylyx PharmaceuticalsAMLX | $3.84B | $30.61 | -7.26% | United States |
| 67 | Telix PharmaceuticalsTLX | $3.82B | $11.27 | -5.69% | Australia |
| 68 | IDEAYA BiosciencesIDYA | $3.61B | $37.46 | -5.67% | United States |
| 69 | Organon & Co.OGN | $3.61B | $13.73 | +0.22% | United States |
| 70 | Legend BiotechLEGN | $3.59B | $18.45 | -1.02% | United States |
| 71 | Xenon PharmaceuticalsXENE | $3.54B | $36.56 | -6.47% | Canada |
| 72 | Enliven TherapeuticsELVN | $3.38B | $46.09 | -4.36% | United States |
| 73 | Arcus BiosciencesRCUS | $3.36B | $26.39 | -1.79% | United States |
| 74 | Arcutis BiotherapeuticsARQT | $3.32B | $26.38 | -5.04% | United States |
| 75 | Dyne TherapeuticsDYN | $3.03B | $16.23 | -5.31% | United States |
| 76 | Zai LabZLAB | $2.97B | $26.44 | +0.11% | China |
| 77 | uniQureQURE | $2.97B | $42.76 | -5.57% | Netherlands |
| 78 | MBX BiosciencesMBX | $2.79B | $57.89 | -6.60% | United States |
| 79 | Vicore Pharma Holding ABVCRE | $2.76B | $9.80 | -3.54% | Sweden |
| 80 | ImmunomeIMNM | $2.75B | $24.24 | -5.86% | United States |
| 81 | NewAmsterdam PharmaNAMS | $2.71B | $22.68 | -2.74% | Netherlands |
| 82 | PrecigenPGEN | $2.66B | $7.44 | -5.70% | United States |
| 83 | Structure TherapeuticsGPCR | $2.56B | $35.95 | -2.60% | United States |
| 84 | Disc MedicineIRON | $2.54B | $66.09 | -3.49% | United States |
| 85 | Supernus PharmaceuticalsSUPN | $2.52B | $43.39 | -0.82% | United States |
| 86 | HUTCHMED (China)HCM | $2.51B | $14.37 | +2.13% | Hong Kong |
| 87 | Nurix TherapeuticsNRIX | $2.48B | $23.88 | -6.97% | United States |
| 88 | Viridian TherapeuticsVRDN | $2.43B | $21.43 | -3.12% | United States |
| 89 | Vera TherapeuticsVERA | $2.38B | $33.05 | -8.85% | United States |
| 90 | Mineralys TherapeuticsMLYS | $2.38B | $26.89 | -8.54% | United States |
| 91 | Harmony BiosciencesHRMY | $2.36B | $40.48 | -2.53% | United States |
| 92 | SELLAS Life Sciences GroupSLS | $2.33B | $11.52 | -4.16% | United States |
| 93 | PharvarisPHVS | $2.30B | $33.07 | -6.05% | Netherlands |
| 94 | Ocular TherapeutixOCUL | $2.20B | $10.00 | -4.76% | United States |
| 95 | SchrodingerSDGR | $2.19B | $29.23 | -4.79% | United States |
| 96 | Aurinia PharmaceuticalsAUPH | $2.18B | $16.40 | -1.62% | Canada |
| 97 | Prestige Consumer HealthcarePBH | $2.18B | $45.92 | -3.79% | United States |
| 98 | Palvella TherapeuticsPVLA | $2.15B | $149.56 | -5.42% | United States |
| 99 | Bausch Health CompaniesBHC | $2.14B | $5.71 | -1.72% | Canada |
| 100 | Generate BiomedicinesGENB | $2.12B | $16.52 | -5.38% | United States |
Showing the largest 100 of 500 companies. One row per company, with secondary share classes folded into their primary listing. Updated 24 Sept 2026.
Sectors biotechnology: pharmaceutical preparations companies sit in
Other industries
Semiconductors 101Computer Software: Programming Data Processing 77Computer Software: Prepackaged Software 234Computer Manufacturing 10Major Banks 246Industrial Machinery/Components 211Catalog/Specialty Distribution 31Business Services 93Commercial Banks 35Auto Manufacturing 29Integrated oil Companies 18Investment Bankers/Brokers/Service 68Oil & Gas Production 116Real Estate Investment Trusts 177Department/Specialty Retail Stores 14Telecommunications Equipment 82Electronic Components 21Beverages (Production/Distribution) 36Finance: Consumer Services 162Electric Utilities: Central 60Consumer Electronics/Appliances 23Biotechnology: Biological Products (No Diagnostic Substances) 160Natural Gas Distribution 29Medical Specialities 44All industries โ
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered: see methodology.